nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—JAK1—systemic lupus erythematosus	0.353	0.514	CbGaD
Ruxolitinib—LTK—systemic lupus erythematosus	0.203	0.295	CbGaD
Ruxolitinib—TYK2—systemic lupus erythematosus	0.131	0.19	CbGaD
Ruxolitinib—DCLK3—urine—systemic lupus erythematosus	0.00347	0.0355	CbGeAlD
Ruxolitinib—Tuberculosis—Leflunomide—systemic lupus erythematosus	0.0034	0.0559	CcSEcCtD
Ruxolitinib—Tuberculosis—Mycophenolate mofetil—systemic lupus erythematosus	0.00256	0.0421	CcSEcCtD
Ruxolitinib—Tuberculosis—Betamethasone—systemic lupus erythematosus	0.00199	0.0327	CcSEcCtD
Ruxolitinib—Tuberculosis—Dexamethasone—systemic lupus erythematosus	0.00199	0.0327	CcSEcCtD
Ruxolitinib—DCLK3—blood plasma—systemic lupus erythematosus	0.00181	0.0185	CbGeAlD
Ruxolitinib—Tuberculosis—Prednisone—systemic lupus erythematosus	0.00174	0.0285	CcSEcCtD
Ruxolitinib—DYRK1A—Mycophenolic acid—Mycophenolate mofetil—systemic lupus erythematosus	0.00163	0.594	CbGdCrCtD
Ruxolitinib—CAMK1—blood plasma—systemic lupus erythematosus	0.00149	0.0153	CbGeAlD
Ruxolitinib—MARK2—blood plasma—systemic lupus erythematosus	0.00145	0.0148	CbGeAlD
Ruxolitinib—Myelosuppression—Azathioprine—systemic lupus erythematosus	0.0014	0.023	CcSEcCtD
Ruxolitinib—PLK1—Mycophenolic acid—Mycophenolate mofetil—systemic lupus erythematosus	0.00111	0.406	CbGdCrCtD
Ruxolitinib—ROCK1—blood plasma—systemic lupus erythematosus	0.00105	0.0108	CbGeAlD
Ruxolitinib—PRKG2—kidney—systemic lupus erythematosus	0.000966	0.00988	CbGeAlD
Ruxolitinib—PLK1—skin of body—systemic lupus erythematosus	0.000919	0.0094	CbGeAlD
Ruxolitinib—Night sweats—Cyclosporine—systemic lupus erythematosus	0.000889	0.0146	CcSEcCtD
Ruxolitinib—Herpes zoster—Azathioprine—systemic lupus erythematosus	0.000874	0.0143	CcSEcCtD
Ruxolitinib—MAP3K2—blood plasma—systemic lupus erythematosus	0.000832	0.00851	CbGeAlD
Ruxolitinib—Herpes zoster—Leflunomide—systemic lupus erythematosus	0.000826	0.0135	CcSEcCtD
Ruxolitinib—ANKK1—nervous system—systemic lupus erythematosus	0.000765	0.00782	CbGeAlD
Ruxolitinib—PLK1—lymphoid tissue—systemic lupus erythematosus	0.000744	0.00761	CbGeAlD
Ruxolitinib—JAK2—blood plasma—systemic lupus erythematosus	0.000736	0.00753	CbGeAlD
Ruxolitinib—PRKCE—tendon—systemic lupus erythematosus	0.000728	0.00745	CbGeAlD
Ruxolitinib—Contusion—Leflunomide—systemic lupus erythematosus	0.000713	0.0117	CcSEcCtD
Ruxolitinib—RPS6KA6—tendon—systemic lupus erythematosus	0.0007	0.00715	CbGeAlD
Ruxolitinib—PRKG2—lung—systemic lupus erythematosus	0.000684	0.007	CbGeAlD
Ruxolitinib—CAMK1—cortex of kidney—systemic lupus erythematosus	0.000659	0.00674	CbGeAlD
Ruxolitinib—JAK3—connective tissue—systemic lupus erythematosus	0.000656	0.00671	CbGeAlD
Ruxolitinib—JAK1—connective tissue—systemic lupus erythematosus	0.000652	0.00666	CbGeAlD
Ruxolitinib—Bone pain—Leflunomide—systemic lupus erythematosus	0.000649	0.0106	CcSEcCtD
Ruxolitinib—TAOK3—blood plasma—systemic lupus erythematosus	0.000647	0.00662	CbGeAlD
Ruxolitinib—PRKCE—lung—systemic lupus erythematosus	0.000639	0.00653	CbGeAlD
Ruxolitinib—Herpes zoster—Cyclosporine—systemic lupus erythematosus	0.000637	0.0105	CcSEcCtD
Ruxolitinib—PRKG2—nervous system—systemic lupus erythematosus	0.000634	0.00648	CbGeAlD
Ruxolitinib—JAK1—nephron tubule—systemic lupus erythematosus	0.000631	0.00646	CbGeAlD
Ruxolitinib—Herpes zoster—Mycophenolate mofetil—systemic lupus erythematosus	0.000622	0.0102	CcSEcCtD
Ruxolitinib—PLK1—lung—systemic lupus erythematosus	0.000614	0.00628	CbGeAlD
Ruxolitinib—RPS6KA6—lung—systemic lupus erythematosus	0.000614	0.00628	CbGeAlD
Ruxolitinib—PRKG2—central nervous system—systemic lupus erythematosus	0.00061	0.00624	CbGeAlD
Ruxolitinib—HIPK2—connective tissue—systemic lupus erythematosus	0.000608	0.00622	CbGeAlD
Ruxolitinib—GRK1—nervous system—systemic lupus erythematosus	0.000605	0.00618	CbGeAlD
Ruxolitinib—PRKCE—nervous system—systemic lupus erythematosus	0.000592	0.00605	CbGeAlD
Ruxolitinib—HIPK2—nephron tubule—systemic lupus erythematosus	0.000589	0.00603	CbGeAlD
Ruxolitinib—JAK1—skin of body—systemic lupus erythematosus	0.000588	0.00602	CbGeAlD
Ruxolitinib—GRK1—central nervous system—systemic lupus erythematosus	0.000582	0.00595	CbGeAlD
Ruxolitinib—PRKCE—central nervous system—systemic lupus erythematosus	0.00057	0.00583	CbGeAlD
Ruxolitinib—MAST1—nervous system—systemic lupus erythematosus	0.000569	0.00581	CbGeAlD
Ruxolitinib—PLK1—nervous system—systemic lupus erythematosus	0.000569	0.00581	CbGeAlD
Ruxolitinib—RPS6KA6—nervous system—systemic lupus erythematosus	0.000569	0.00581	CbGeAlD
Ruxolitinib—ROCK1—connective tissue—systemic lupus erythematosus	0.000561	0.00574	CbGeAlD
Ruxolitinib—JAK1—kidney—systemic lupus erythematosus	0.000555	0.00567	CbGeAlD
Ruxolitinib—RPS6KA6—central nervous system—systemic lupus erythematosus	0.000547	0.0056	CbGeAlD
Ruxolitinib—PLK1—central nervous system—systemic lupus erythematosus	0.000547	0.0056	CbGeAlD
Ruxolitinib—MAST1—central nervous system—systemic lupus erythematosus	0.000547	0.0056	CbGeAlD
Ruxolitinib—CAMK1—tendon—systemic lupus erythematosus	0.000546	0.00558	CbGeAlD
Ruxolitinib—BMPR2—connective tissue—systemic lupus erythematosus	0.000545	0.00557	CbGeAlD
Ruxolitinib—JAK1—cortex of kidney—systemic lupus erythematosus	0.00054	0.00553	CbGeAlD
Ruxolitinib—DCLK3—nervous system—systemic lupus erythematosus	0.000539	0.00551	CbGeAlD
Ruxolitinib—MARK2—tendon—systemic lupus erythematosus	0.00053	0.00542	CbGeAlD
Ruxolitinib—DCLK3—central nervous system—systemic lupus erythematosus	0.000519	0.00531	CbGeAlD
Ruxolitinib—HIPK2—kidney—systemic lupus erythematosus	0.000518	0.0053	CbGeAlD
Ruxolitinib—DAPK2—cortex of kidney—systemic lupus erythematosus	0.000515	0.00527	CbGeAlD
Ruxolitinib—PLK3—lung—systemic lupus erythematosus	0.000512	0.00524	CbGeAlD
Ruxolitinib—NUAK2—nephron tubule—systemic lupus erythematosus	0.000505	0.00516	CbGeAlD
Ruxolitinib—HIPK2—cortex of kidney—systemic lupus erythematosus	0.000504	0.00516	CbGeAlD
Ruxolitinib—LTK—lung—systemic lupus erythematosus	0.000495	0.00506	CbGeAlD
Ruxolitinib—Hypercholesterolaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000495	0.00812	CcSEcCtD
Ruxolitinib—BMPR2—skin of body—systemic lupus erythematosus	0.000492	0.00503	CbGeAlD
Ruxolitinib—TAOK2—tendon—systemic lupus erythematosus	0.000491	0.00502	CbGeAlD
Ruxolitinib—Contusion—Hydrocortisone—systemic lupus erythematosus	0.000489	0.00802	CcSEcCtD
Ruxolitinib—Bone pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000489	0.00802	CcSEcCtD
Ruxolitinib—BMP2K—connective tissue—systemic lupus erythematosus	0.000488	0.00499	CbGeAlD
Ruxolitinib—CLK2—cortex of kidney—systemic lupus erythematosus	0.00048	0.00491	CbGeAlD
Ruxolitinib—JAK3—lymphoid tissue—systemic lupus erythematosus	0.00048	0.0049	CbGeAlD
Ruxolitinib—CAMK1—lung—systemic lupus erythematosus	0.000479	0.0049	CbGeAlD
Ruxolitinib—ROCK1—kidney—systemic lupus erythematosus	0.000478	0.00489	CbGeAlD
Ruxolitinib—JAK1—lymphoid tissue—systemic lupus erythematosus	0.000477	0.00487	CbGeAlD
Ruxolitinib—PLK3—nervous system—systemic lupus erythematosus	0.000474	0.00485	CbGeAlD
Ruxolitinib—PLK4—lymphoid tissue—systemic lupus erythematosus	0.000474	0.00484	CbGeAlD
Ruxolitinib—DYRK1A—kidney—systemic lupus erythematosus	0.000466	0.00476	CbGeAlD
Ruxolitinib—MARK2—lung—systemic lupus erythematosus	0.000465	0.00476	CbGeAlD
Ruxolitinib—BMPR2—kidney—systemic lupus erythematosus	0.000464	0.00475	CbGeAlD
Ruxolitinib—PLK3—central nervous system—systemic lupus erythematosus	0.000457	0.00467	CbGeAlD
Ruxolitinib—BMPR2—cortex of kidney—systemic lupus erythematosus	0.000452	0.00462	CbGeAlD
Ruxolitinib—JAK1—tendon—systemic lupus erythematosus	0.000448	0.00458	CbGeAlD
Ruxolitinib—DCLK1—tendon—systemic lupus erythematosus	0.000448	0.00458	CbGeAlD
Ruxolitinib—STK16—lymphoid tissue—systemic lupus erythematosus	0.000447	0.00457	CbGeAlD
Ruxolitinib—HIPK2—lymphoid tissue—systemic lupus erythematosus	0.000445	0.00455	CbGeAlD
Ruxolitinib—CAMK1—nervous system—systemic lupus erythematosus	0.000444	0.00454	CbGeAlD
Ruxolitinib—MAP3K2—connective tissue—systemic lupus erythematosus	0.000443	0.00453	CbGeAlD
Ruxolitinib—CAMK1D—tendon—systemic lupus erythematosus	0.000437	0.00447	CbGeAlD
Ruxolitinib—PHKG2—tendon—systemic lupus erythematosus	0.000435	0.00444	CbGeAlD
Ruxolitinib—JAK1—bone marrow—systemic lupus erythematosus	0.000434	0.00444	CbGeAlD
Ruxolitinib—NUAK2—cortex of kidney—systemic lupus erythematosus	0.000432	0.00442	CbGeAlD
Ruxolitinib—PLK4—bone marrow—systemic lupus erythematosus	0.000431	0.00441	CbGeAlD
Ruxolitinib—TYK2—connective tissue—systemic lupus erythematosus	0.000431	0.00441	CbGeAlD
Ruxolitinib—MARK2—nervous system—systemic lupus erythematosus	0.000431	0.00441	CbGeAlD
Ruxolitinib—TAOK2—lung—systemic lupus erythematosus	0.00043	0.0044	CbGeAlD
Ruxolitinib—MAP3K2—nephron tubule—systemic lupus erythematosus	0.000429	0.00439	CbGeAlD
Ruxolitinib—DAPK2—tendon—systemic lupus erythematosus	0.000427	0.00437	CbGeAlD
Ruxolitinib—CAMK1—central nervous system—systemic lupus erythematosus	0.000427	0.00437	CbGeAlD
Ruxolitinib—MKNK2—connective tissue—systemic lupus erythematosus	0.000425	0.00435	CbGeAlD
Ruxolitinib—CLK2—lymphoid tissue—systemic lupus erythematosus	0.000423	0.00433	CbGeAlD
Ruxolitinib—STK16—tendon—systemic lupus erythematosus	0.00042	0.0043	CbGeAlD
Ruxolitinib—HIPK2—tendon—systemic lupus erythematosus	0.000418	0.00428	CbGeAlD
Ruxolitinib—Contusion—Dexamethasone—systemic lupus erythematosus	0.000418	0.00685	CcSEcCtD
Ruxolitinib—Contusion—Betamethasone—systemic lupus erythematosus	0.000418	0.00685	CcSEcCtD
Ruxolitinib—TYK2—nephron tubule—systemic lupus erythematosus	0.000417	0.00427	CbGeAlD
Ruxolitinib—RET—connective tissue—systemic lupus erythematosus	0.000415	0.00424	CbGeAlD
Ruxolitinib—MARK2—central nervous system—systemic lupus erythematosus	0.000415	0.00424	CbGeAlD
Ruxolitinib—DAPK2—bone marrow—systemic lupus erythematosus	0.000414	0.00423	CbGeAlD
Ruxolitinib—IRAK1—nephron tubule—systemic lupus erythematosus	0.000412	0.00421	CbGeAlD
Ruxolitinib—MKNK2—nephron tubule—systemic lupus erythematosus	0.000412	0.00421	CbGeAlD
Ruxolitinib—LRRK2—kidney—systemic lupus erythematosus	0.000412	0.00421	CbGeAlD
Ruxolitinib—ROCK1—lymphoid tissue—systemic lupus erythematosus	0.00041	0.0042	CbGeAlD
Ruxolitinib—CAMK2G—cortex of kidney—systemic lupus erythematosus	0.000404	0.00414	CbGeAlD
Ruxolitinib—DAPK3—tendon—systemic lupus erythematosus	0.000402	0.00411	CbGeAlD
Ruxolitinib—LRRK2—cortex of kidney—systemic lupus erythematosus	0.000401	0.0041	CbGeAlD
Ruxolitinib—DYRK1A—lymphoid tissue—systemic lupus erythematosus	0.0004	0.00409	CbGeAlD
Ruxolitinib—BMPR2—lymphoid tissue—systemic lupus erythematosus	0.000399	0.00408	CbGeAlD
Ruxolitinib—CLK2—tendon—systemic lupus erythematosus	0.000398	0.00407	CbGeAlD
Ruxolitinib—JAK3—lung—systemic lupus erythematosus	0.000396	0.00405	CbGeAlD
Ruxolitinib—DCLK1—lung—systemic lupus erythematosus	0.000393	0.00402	CbGeAlD
Ruxolitinib—JAK1—lung—systemic lupus erythematosus	0.000393	0.00402	CbGeAlD
Ruxolitinib—Pancytopenia—Azathioprine—systemic lupus erythematosus	0.000392	0.00644	CcSEcCtD
Ruxolitinib—JAK2—connective tissue—systemic lupus erythematosus	0.000392	0.00401	CbGeAlD
Ruxolitinib—PLK4—lung—systemic lupus erythematosus	0.000391	0.004	CbGeAlD
Ruxolitinib—TYK2—skin of body—systemic lupus erythematosus	0.000389	0.00398	CbGeAlD
Ruxolitinib—CLK2—bone marrow—systemic lupus erythematosus	0.000386	0.00394	CbGeAlD
Ruxolitinib—CAMK1D—lung—systemic lupus erythematosus	0.000384	0.00392	CbGeAlD
Ruxolitinib—PHKG2—lung—systemic lupus erythematosus	0.000381	0.0039	CbGeAlD
Ruxolitinib—CYP3A4—urine—systemic lupus erythematosus	0.000377	0.00385	CbGeAlD
Ruxolitinib—DAPK2—lung—systemic lupus erythematosus	0.000375	0.00383	CbGeAlD
Ruxolitinib—BMPR2—tendon—systemic lupus erythematosus	0.000375	0.00383	CbGeAlD
Ruxolitinib—Pancytopenia—Leflunomide—systemic lupus erythematosus	0.00037	0.00608	CcSEcCtD
Ruxolitinib—STK16—lung—systemic lupus erythematosus	0.000369	0.00377	CbGeAlD
Ruxolitinib—Infestation—Azathioprine—systemic lupus erythematosus	0.000368	0.00604	CcSEcCtD
Ruxolitinib—Infestation NOS—Azathioprine—systemic lupus erythematosus	0.000368	0.00604	CcSEcCtD
Ruxolitinib—HIPK2—lung—systemic lupus erythematosus	0.000367	0.00375	CbGeAlD
Ruxolitinib—TYK2—kidney—systemic lupus erythematosus	0.000367	0.00375	CbGeAlD
Ruxolitinib—JAK3—nervous system—systemic lupus erythematosus	0.000366	0.00375	CbGeAlD
Ruxolitinib—MAP3K3—nephron tubule—systemic lupus erythematosus	0.000366	0.00374	CbGeAlD
Ruxolitinib—Neutropenia—Leflunomide—systemic lupus erythematosus	0.000365	0.00598	CcSEcCtD
Ruxolitinib—DCLK1—nervous system—systemic lupus erythematosus	0.000364	0.00372	CbGeAlD
Ruxolitinib—JAK1—nervous system—systemic lupus erythematosus	0.000364	0.00372	CbGeAlD
Ruxolitinib—MAP3K7—cortex of kidney—systemic lupus erythematosus	0.000364	0.00372	CbGeAlD
Ruxolitinib—Contusion—Prednisone—systemic lupus erythematosus	0.000364	0.00597	CcSEcCtD
Ruxolitinib—MAP3K19—lung—systemic lupus erythematosus	0.00036	0.00368	CbGeAlD
Ruxolitinib—TYK2—cortex of kidney—systemic lupus erythematosus	0.000357	0.00365	CbGeAlD
Ruxolitinib—CAMK1D—nervous system—systemic lupus erythematosus	0.000355	0.00363	CbGeAlD
Ruxolitinib—JAK2—skin of body—systemic lupus erythematosus	0.000354	0.00362	CbGeAlD
Ruxolitinib—PHKG2—nervous system—systemic lupus erythematosus	0.000353	0.00361	CbGeAlD
Ruxolitinib—RET—kidney—systemic lupus erythematosus	0.000353	0.00361	CbGeAlD
Ruxolitinib—Weight decreased—Leflunomide—systemic lupus erythematosus	0.000353	0.00579	CcSEcCtD
Ruxolitinib—JAK3—central nervous system—systemic lupus erythematosus	0.000353	0.00361	CbGeAlD
Ruxolitinib—MKNK2—cortex of kidney—systemic lupus erythematosus	0.000353	0.00361	CbGeAlD
Ruxolitinib—IRAK1—cortex of kidney—systemic lupus erythematosus	0.000353	0.00361	CbGeAlD
Ruxolitinib—DAPK3—lung—systemic lupus erythematosus	0.000353	0.00361	CbGeAlD
Ruxolitinib—Herpes zoster—Methotrexate—systemic lupus erythematosus	0.000352	0.00578	CcSEcCtD
Ruxolitinib—JAK1—central nervous system—systemic lupus erythematosus	0.00035	0.00358	CbGeAlD
Ruxolitinib—DCLK1—central nervous system—systemic lupus erythematosus	0.00035	0.00358	CbGeAlD
Ruxolitinib—CLK2—lung—systemic lupus erythematosus	0.000349	0.00357	CbGeAlD
Ruxolitinib—Hepatobiliary disease—Azathioprine—systemic lupus erythematosus	0.000348	0.00571	CcSEcCtD
Ruxolitinib—Infestation NOS—Leflunomide—systemic lupus erythematosus	0.000348	0.00571	CcSEcCtD
Ruxolitinib—Infestation—Leflunomide—systemic lupus erythematosus	0.000348	0.00571	CcSEcCtD
Ruxolitinib—NUAK2—bone marrow—systemic lupus erythematosus	0.000347	0.00355	CbGeAlD
Ruxolitinib—TAOK3—connective tissue—systemic lupus erythematosus	0.000345	0.00352	CbGeAlD
Ruxolitinib—CAMK1D—central nervous system—systemic lupus erythematosus	0.000342	0.0035	CbGeAlD
Ruxolitinib—STK16—nervous system—systemic lupus erythematosus	0.000342	0.00349	CbGeAlD
Ruxolitinib—MAP3K3—skin of body—systemic lupus erythematosus	0.000341	0.00349	CbGeAlD
Ruxolitinib—PHKG2—central nervous system—systemic lupus erythematosus	0.00034	0.00348	CbGeAlD
Ruxolitinib—HIPK2—nervous system—systemic lupus erythematosus	0.00034	0.00348	CbGeAlD
Ruxolitinib—Gastrointestinal haemorrhage—Mycophenolate mofetil—systemic lupus erythematosus	0.00034	0.00558	CcSEcCtD
Ruxolitinib—ROCK1—lung—systemic lupus erythematosus	0.000339	0.00346	CbGeAlD
Ruxolitinib—Urinary tract infection—Leflunomide—systemic lupus erythematosus	0.000338	0.00555	CcSEcCtD
Ruxolitinib—Hypercholesterolaemia—Prednisone—systemic lupus erythematosus	0.000335	0.0055	CcSEcCtD
Ruxolitinib—CAMK2G—tendon—systemic lupus erythematosus	0.000335	0.00343	CbGeAlD
Ruxolitinib—BMP2K—tendon—systemic lupus erythematosus	0.000335	0.00343	CbGeAlD
Ruxolitinib—JAK2—kidney—systemic lupus erythematosus	0.000334	0.00341	CbGeAlD
Ruxolitinib—TAOK3—nephron tubule—systemic lupus erythematosus	0.000334	0.00341	CbGeAlD
Ruxolitinib—MAP3K19—nervous system—systemic lupus erythematosus	0.000333	0.0034	CbGeAlD
Ruxolitinib—LRRK2—tendon—systemic lupus erythematosus	0.000332	0.0034	CbGeAlD
Ruxolitinib—Haemoglobin—Azathioprine—systemic lupus erythematosus	0.000332	0.00545	CcSEcCtD
Ruxolitinib—Haematuria—Leflunomide—systemic lupus erythematosus	0.000332	0.00544	CcSEcCtD
Ruxolitinib—Haemorrhage—Azathioprine—systemic lupus erythematosus	0.000331	0.00542	CcSEcCtD
Ruxolitinib—DYRK1A—lung—systemic lupus erythematosus	0.00033	0.00338	CbGeAlD
Ruxolitinib—STK16—central nervous system—systemic lupus erythematosus	0.000329	0.00336	CbGeAlD
Ruxolitinib—Hepatobiliary disease—Leflunomide—systemic lupus erythematosus	0.000329	0.0054	CcSEcCtD
Ruxolitinib—BMPR2—lung—systemic lupus erythematosus	0.000329	0.00336	CbGeAlD
Ruxolitinib—Body temperature increased—Dapsone—systemic lupus erythematosus	0.000328	0.00539	CcSEcCtD
Ruxolitinib—Epistaxis—Leflunomide—systemic lupus erythematosus	0.000328	0.00538	CcSEcCtD
Ruxolitinib—HIPK2—central nervous system—systemic lupus erythematosus	0.000327	0.00335	CbGeAlD
Ruxolitinib—DAPK3—nervous system—systemic lupus erythematosus	0.000327	0.00334	CbGeAlD
Ruxolitinib—JAK2—cortex of kidney—systemic lupus erythematosus	0.000325	0.00332	CbGeAlD
Ruxolitinib—CAMK2G—bone marrow—systemic lupus erythematosus	0.000325	0.00332	CbGeAlD
Ruxolitinib—BMP2K—bone marrow—systemic lupus erythematosus	0.000325	0.00332	CbGeAlD
Ruxolitinib—MAP3K2—lymphoid tissue—systemic lupus erythematosus	0.000324	0.00331	CbGeAlD
Ruxolitinib—CLK2—nervous system—systemic lupus erythematosus	0.000323	0.00331	CbGeAlD
Ruxolitinib—LRRK2—bone marrow—systemic lupus erythematosus	0.000322	0.00329	CbGeAlD
Ruxolitinib—MAP3K19—central nervous system—systemic lupus erythematosus	0.000321	0.00328	CbGeAlD
Ruxolitinib—TYK2—lymphoid tissue—systemic lupus erythematosus	0.000315	0.00322	CbGeAlD
Ruxolitinib—DAPK3—central nervous system—systemic lupus erythematosus	0.000314	0.00321	CbGeAlD
Ruxolitinib—NUAK2—lung—systemic lupus erythematosus	0.000314	0.00321	CbGeAlD
Ruxolitinib—Haemoglobin—Leflunomide—systemic lupus erythematosus	0.000314	0.00515	CcSEcCtD
Ruxolitinib—ROCK1—nervous system—systemic lupus erythematosus	0.000313	0.00321	CbGeAlD
Ruxolitinib—MAP3K3—cortex of kidney—systemic lupus erythematosus	0.000313	0.0032	CbGeAlD
Ruxolitinib—Haemorrhage—Leflunomide—systemic lupus erythematosus	0.000312	0.00512	CcSEcCtD
Ruxolitinib—CLK2—central nervous system—systemic lupus erythematosus	0.000311	0.00318	CbGeAlD
Ruxolitinib—MKNK2—lymphoid tissue—systemic lupus erythematosus	0.000311	0.00318	CbGeAlD
Ruxolitinib—DYRK1A—nervous system—systemic lupus erythematosus	0.000306	0.00313	CbGeAlD
Ruxolitinib—BMPR2—nervous system—systemic lupus erythematosus	0.000305	0.00311	CbGeAlD
Ruxolitinib—RET—lymphoid tissue—systemic lupus erythematosus	0.000303	0.0031	CbGeAlD
Ruxolitinib—ROCK1—central nervous system—systemic lupus erythematosus	0.000302	0.00309	CbGeAlD
Ruxolitinib—MAP3K7—tendon—systemic lupus erythematosus	0.000302	0.00308	CbGeAlD
Ruxolitinib—Alanine aminotransferase increased—Mycophenolate mofetil—systemic lupus erythematosus	0.0003	0.00492	CcSEcCtD
Ruxolitinib—TYK2—tendon—systemic lupus erythematosus	0.000296	0.00303	CbGeAlD
Ruxolitinib—MAP3K2—bone marrow—systemic lupus erythematosus	0.000295	0.00302	CbGeAlD
Ruxolitinib—DYRK1A—central nervous system—systemic lupus erythematosus	0.000294	0.00301	CbGeAlD
Ruxolitinib—CAMK2G—lung—systemic lupus erythematosus	0.000294	0.00301	CbGeAlD
Ruxolitinib—BMP2K—lung—systemic lupus erythematosus	0.000294	0.00301	CbGeAlD
Ruxolitinib—TAOK3—kidney—systemic lupus erythematosus	0.000293	0.003	CbGeAlD
Ruxolitinib—BMPR2—central nervous system—systemic lupus erythematosus	0.000293	0.003	CbGeAlD
Ruxolitinib—IRAK1—tendon—systemic lupus erythematosus	0.000292	0.00299	CbGeAlD
Ruxolitinib—MKNK2—tendon—systemic lupus erythematosus	0.000292	0.00299	CbGeAlD
Ruxolitinib—MAP3K7—bone marrow—systemic lupus erythematosus	0.000292	0.00299	CbGeAlD
Ruxolitinib—LRRK2—lung—systemic lupus erythematosus	0.000292	0.00298	CbGeAlD
Ruxolitinib—TYK2—bone marrow—systemic lupus erythematosus	0.000287	0.00293	CbGeAlD
Ruxolitinib—JAK2—lymphoid tissue—systemic lupus erythematosus	0.000287	0.00293	CbGeAlD
Ruxolitinib—TAOK3—cortex of kidney—systemic lupus erythematosus	0.000286	0.00292	CbGeAlD
Ruxolitinib—RET—tendon—systemic lupus erythematosus	0.000285	0.00292	CbGeAlD
Ruxolitinib—IRAK1—bone marrow—systemic lupus erythematosus	0.000283	0.0029	CbGeAlD
Ruxolitinib—MKNK2—bone marrow—systemic lupus erythematosus	0.000283	0.0029	CbGeAlD
Ruxolitinib—Pancytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000279	0.00458	CcSEcCtD
Ruxolitinib—Neutropenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000275	0.00451	CcSEcCtD
Ruxolitinib—Weight increased—Cyclosporine—systemic lupus erythematosus	0.000274	0.0045	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Hydrocortisone—systemic lupus erythematosus	0.000273	0.00448	CcSEcCtD
Ruxolitinib—BMP2K—nervous system—systemic lupus erythematosus	0.000273	0.00279	CbGeAlD
Ruxolitinib—CAMK2G—nervous system—systemic lupus erythematosus	0.000273	0.00279	CbGeAlD
Ruxolitinib—Weight decreased—Cyclosporine—systemic lupus erythematosus	0.000272	0.00447	CcSEcCtD
Ruxolitinib—Malnutrition—Leflunomide—systemic lupus erythematosus	0.000272	0.00446	CcSEcCtD
Ruxolitinib—LRRK2—nervous system—systemic lupus erythematosus	0.00027	0.00276	CbGeAlD
Ruxolitinib—JAK2—tendon—systemic lupus erythematosus	0.000269	0.00276	CbGeAlD
Ruxolitinib—Infestation NOS—Cyclosporine—systemic lupus erythematosus	0.000268	0.0044	CcSEcCtD
Ruxolitinib—Infestation—Cyclosporine—systemic lupus erythematosus	0.000268	0.0044	CcSEcCtD
Ruxolitinib—Flatulence—Leflunomide—systemic lupus erythematosus	0.000268	0.00439	CcSEcCtD
Ruxolitinib—Weight increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000267	0.00439	CcSEcCtD
Ruxolitinib—MAP3K2—lung—systemic lupus erythematosus	0.000267	0.00273	CbGeAlD
Ruxolitinib—Anaemia—Azathioprine—systemic lupus erythematosus	0.000266	0.00436	CcSEcCtD
Ruxolitinib—Weight decreased—Mycophenolate mofetil—systemic lupus erythematosus	0.000266	0.00436	CcSEcCtD
Ruxolitinib—MAP3K7—lung—systemic lupus erythematosus	0.000265	0.00271	CbGeAlD
Ruxolitinib—CAMK2G—central nervous system—systemic lupus erythematosus	0.000262	0.00268	CbGeAlD
Ruxolitinib—BMP2K—central nervous system—systemic lupus erythematosus	0.000262	0.00268	CbGeAlD
Ruxolitinib—Infestation—Mycophenolate mofetil—systemic lupus erythematosus	0.000262	0.0043	CcSEcCtD
Ruxolitinib—Infestation NOS—Mycophenolate mofetil—systemic lupus erythematosus	0.000262	0.0043	CcSEcCtD
Ruxolitinib—JAK2—bone marrow—systemic lupus erythematosus	0.000261	0.00267	CbGeAlD
Ruxolitinib—Urinary tract infection—Cyclosporine—systemic lupus erythematosus	0.000261	0.00428	CcSEcCtD
Ruxolitinib—Headache—Dapsone—systemic lupus erythematosus	0.00026	0.00427	CcSEcCtD
Ruxolitinib—LRRK2—central nervous system—systemic lupus erythematosus	0.00026	0.00266	CbGeAlD
Ruxolitinib—TYK2—lung—systemic lupus erythematosus	0.00026	0.00266	CbGeAlD
Ruxolitinib—MAP3K3—tendon—systemic lupus erythematosus	0.00026	0.00266	CbGeAlD
Ruxolitinib—IRAK1—lung—systemic lupus erythematosus	0.000257	0.00262	CbGeAlD
Ruxolitinib—MKNK2—lung—systemic lupus erythematosus	0.000257	0.00262	CbGeAlD
Ruxolitinib—Alanine aminotransferase increased—Methylprednisolone—systemic lupus erythematosus	0.000256	0.00421	CcSEcCtD
Ruxolitinib—Haematuria—Cyclosporine—systemic lupus erythematosus	0.000256	0.0042	CcSEcCtD
Ruxolitinib—Urinary tract infection—Mycophenolate mofetil—systemic lupus erythematosus	0.000254	0.00418	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Cyclosporine—systemic lupus erythematosus	0.000254	0.00417	CcSEcCtD
Ruxolitinib—Epistaxis—Cyclosporine—systemic lupus erythematosus	0.000253	0.00415	CcSEcCtD
Ruxolitinib—TAOK3—lymphoid tissue—systemic lupus erythematosus	0.000252	0.00258	CbGeAlD
Ruxolitinib—MAP3K3—bone marrow—systemic lupus erythematosus	0.000252	0.00257	CbGeAlD
Ruxolitinib—Anaemia—Leflunomide—systemic lupus erythematosus	0.000251	0.00412	CcSEcCtD
Ruxolitinib—Haematuria—Mycophenolate mofetil—systemic lupus erythematosus	0.00025	0.0041	CcSEcCtD
Ruxolitinib—Weight increased—Prednisolone—systemic lupus erythematosus	0.000249	0.00409	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Mycophenolate mofetil—systemic lupus erythematosus	0.000248	0.00406	CcSEcCtD
Ruxolitinib—MAP3K2—nervous system—systemic lupus erythematosus	0.000247	0.00253	CbGeAlD
Ruxolitinib—Epistaxis—Mycophenolate mofetil—systemic lupus erythematosus	0.000247	0.00405	CcSEcCtD
Ruxolitinib—Weight increased—Hydrocortisone—systemic lupus erythematosus	0.000243	0.00399	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic lupus erythematosus	0.000243	0.00399	CcSEcCtD
Ruxolitinib—Haemoglobin—Cyclosporine—systemic lupus erythematosus	0.000242	0.00397	CcSEcCtD
Ruxolitinib—Weight decreased—Hydrocortisone—systemic lupus erythematosus	0.000242	0.00397	CcSEcCtD
Ruxolitinib—Haemorrhage—Cyclosporine—systemic lupus erythematosus	0.000241	0.00395	CcSEcCtD
Ruxolitinib—TYK2—nervous system—systemic lupus erythematosus	0.000241	0.00246	CbGeAlD
Ruxolitinib—Infestation—Hydrocortisone—systemic lupus erythematosus	0.000239	0.00391	CcSEcCtD
Ruxolitinib—Infestation NOS—Hydrocortisone—systemic lupus erythematosus	0.000239	0.00391	CcSEcCtD
Ruxolitinib—MAP3K2—central nervous system—systemic lupus erythematosus	0.000238	0.00244	CbGeAlD
Ruxolitinib—MKNK2—nervous system—systemic lupus erythematosus	0.000238	0.00243	CbGeAlD
Ruxolitinib—TAOK3—tendon—systemic lupus erythematosus	0.000237	0.00242	CbGeAlD
Ruxolitinib—JAK2—lung—systemic lupus erythematosus	0.000236	0.00242	CbGeAlD
Ruxolitinib—Haemoglobin—Mycophenolate mofetil—systemic lupus erythematosus	0.000236	0.00388	CcSEcCtD
Ruxolitinib—Haemorrhage—Mycophenolate mofetil—systemic lupus erythematosus	0.000235	0.00386	CcSEcCtD
Ruxolitinib—Infection—Azathioprine—systemic lupus erythematosus	0.000233	0.00383	CcSEcCtD
Ruxolitinib—TYK2—central nervous system—systemic lupus erythematosus	0.000232	0.00237	CbGeAlD
Ruxolitinib—RET—nervous system—systemic lupus erythematosus	0.000232	0.00237	CbGeAlD
Ruxolitinib—Gastrointestinal haemorrhage—Prednisone—systemic lupus erythematosus	0.00023	0.00378	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Azathioprine—systemic lupus erythematosus	0.00023	0.00377	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic lupus erythematosus	0.00023	0.00377	CcSEcCtD
Ruxolitinib—TAOK3—bone marrow—systemic lupus erythematosus	0.000229	0.00235	CbGeAlD
Ruxolitinib—Weight increased—Triamcinolone—systemic lupus erythematosus	0.000229	0.00376	CcSEcCtD
Ruxolitinib—MKNK2—central nervous system—systemic lupus erythematosus	0.000229	0.00234	CbGeAlD
Ruxolitinib—Weight increased—Methylprednisolone—systemic lupus erythematosus	0.000229	0.00375	CcSEcCtD
Ruxolitinib—Skin disorder—Azathioprine—systemic lupus erythematosus	0.000228	0.00374	CcSEcCtD
Ruxolitinib—MAP3K3—lung—systemic lupus erythematosus	0.000228	0.00233	CbGeAlD
Ruxolitinib—Infestation—Methylprednisolone—systemic lupus erythematosus	0.000224	0.00368	CcSEcCtD
Ruxolitinib—Infestation NOS—Methylprednisolone—systemic lupus erythematosus	0.000224	0.00368	CcSEcCtD
Ruxolitinib—RET—central nervous system—systemic lupus erythematosus	0.000223	0.00228	CbGeAlD
Ruxolitinib—Haemoglobin—Prednisolone—systemic lupus erythematosus	0.00022	0.00362	CcSEcCtD
Ruxolitinib—Infection—Leflunomide—systemic lupus erythematosus	0.00022	0.00362	CcSEcCtD
Ruxolitinib—Haemorrhage—Prednisolone—systemic lupus erythematosus	0.000219	0.0036	CcSEcCtD
Ruxolitinib—JAK2—nervous system—systemic lupus erythematosus	0.000219	0.00224	CbGeAlD
Ruxolitinib—Nervous system disorder—Leflunomide—systemic lupus erythematosus	0.000218	0.00357	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Leflunomide—systemic lupus erythematosus	0.000217	0.00356	CcSEcCtD
Ruxolitinib—Skin disorder—Leflunomide—systemic lupus erythematosus	0.000215	0.00354	CcSEcCtD
Ruxolitinib—Haemoglobin—Hydrocortisone—systemic lupus erythematosus	0.000215	0.00353	CcSEcCtD
Ruxolitinib—Haemorrhage—Hydrocortisone—systemic lupus erythematosus	0.000214	0.00351	CcSEcCtD
Ruxolitinib—Epistaxis—Triamcinolone—systemic lupus erythematosus	0.000212	0.00348	CcSEcCtD
Ruxolitinib—MAP3K3—nervous system—systemic lupus erythematosus	0.000211	0.00216	CbGeAlD
Ruxolitinib—JAK2—central nervous system—systemic lupus erythematosus	0.000211	0.00216	CbGeAlD
Ruxolitinib—Malnutrition—Cyclosporine—systemic lupus erythematosus	0.00021	0.00344	CcSEcCtD
Ruxolitinib—Weight increased—Betamethasone—systemic lupus erythematosus	0.000208	0.00341	CcSEcCtD
Ruxolitinib—Weight increased—Dexamethasone—systemic lupus erythematosus	0.000208	0.00341	CcSEcCtD
Ruxolitinib—TAOK3—lung—systemic lupus erythematosus	0.000208	0.00213	CbGeAlD
Ruxolitinib—Weight decreased—Betamethasone—systemic lupus erythematosus	0.000207	0.00339	CcSEcCtD
Ruxolitinib—Weight decreased—Dexamethasone—systemic lupus erythematosus	0.000207	0.00339	CcSEcCtD
Ruxolitinib—Flatulence—Cyclosporine—systemic lupus erythematosus	0.000207	0.00339	CcSEcCtD
Ruxolitinib—Malnutrition—Mycophenolate mofetil—systemic lupus erythematosus	0.000205	0.00336	CcSEcCtD
Ruxolitinib—MAP3K3—central nervous system—systemic lupus erythematosus	0.000203	0.00208	CbGeAlD
Ruxolitinib—Alanine aminotransferase increased—Prednisone—systemic lupus erythematosus	0.000203	0.00333	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000203	0.00333	CcSEcCtD
Ruxolitinib—Haemoglobin—Triamcinolone—systemic lupus erythematosus	0.000203	0.00333	CcSEcCtD
Ruxolitinib—Haemoglobin—Methylprednisolone—systemic lupus erythematosus	0.000202	0.00332	CcSEcCtD
Ruxolitinib—Haemorrhage—Triamcinolone—systemic lupus erythematosus	0.000202	0.00331	CcSEcCtD
Ruxolitinib—Flatulence—Mycophenolate mofetil—systemic lupus erythematosus	0.000202	0.00331	CcSEcCtD
Ruxolitinib—Haemorrhage—Methylprednisolone—systemic lupus erythematosus	0.000201	0.0033	CcSEcCtD
Ruxolitinib—CYP3A4—blood plasma—systemic lupus erythematosus	0.000197	0.00201	CbGeAlD
Ruxolitinib—Anaemia—Cyclosporine—systemic lupus erythematosus	0.000194	0.00318	CcSEcCtD
Ruxolitinib—TAOK3—nervous system—systemic lupus erythematosus	0.000192	0.00197	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000191	0.00314	CcSEcCtD
Ruxolitinib—Fatigue—Leflunomide—systemic lupus erythematosus	0.000191	0.00314	CcSEcCtD
Ruxolitinib—Anaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000189	0.0031	CcSEcCtD
Ruxolitinib—Malnutrition—Hydrocortisone—systemic lupus erythematosus	0.000186	0.00306	CcSEcCtD
Ruxolitinib—Neutropenia—Prednisone—systemic lupus erythematosus	0.000186	0.00305	CcSEcCtD
Ruxolitinib—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.000186	0.00305	CcSEcCtD
Ruxolitinib—TAOK3—central nervous system—systemic lupus erythematosus	0.000185	0.00189	CbGeAlD
Ruxolitinib—Haemoglobin—Dexamethasone—systemic lupus erythematosus	0.000184	0.00302	CcSEcCtD
Ruxolitinib—Haemoglobin—Betamethasone—systemic lupus erythematosus	0.000184	0.00302	CcSEcCtD
Ruxolitinib—Haemorrhage—Betamethasone—systemic lupus erythematosus	0.000183	0.003	CcSEcCtD
Ruxolitinib—Haemorrhage—Dexamethasone—systemic lupus erythematosus	0.000183	0.003	CcSEcCtD
Ruxolitinib—Weight increased—Prednisone—systemic lupus erythematosus	0.000181	0.00297	CcSEcCtD
Ruxolitinib—Weight decreased—Prednisone—systemic lupus erythematosus	0.00018	0.00295	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.000177	0.00291	CcSEcCtD
Ruxolitinib—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.000175	0.00288	CcSEcCtD
Ruxolitinib—Malnutrition—Methylprednisolone—systemic lupus erythematosus	0.000175	0.00287	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000173	0.00284	CcSEcCtD
Ruxolitinib—Infection—Cyclosporine—systemic lupus erythematosus	0.00017	0.00279	CcSEcCtD
Ruxolitinib—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000168	0.00275	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.000168	0.00275	CcSEcCtD
Ruxolitinib—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000166	0.00273	CcSEcCtD
Ruxolitinib—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.000166	0.00272	CcSEcCtD
Ruxolitinib—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000164	0.00269	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000163	0.00268	CcSEcCtD
Ruxolitinib—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000162	0.00266	CcSEcCtD
Ruxolitinib—Haemoglobin—Prednisone—systemic lupus erythematosus	0.00016	0.00263	CcSEcCtD
Ruxolitinib—Haemorrhage—Prednisone—systemic lupus erythematosus	0.000159	0.00261	CcSEcCtD
Ruxolitinib—Asthenia—Leflunomide—systemic lupus erythematosus	0.000159	0.00261	CcSEcCtD
Ruxolitinib—Pancytopenia—Methotrexate—systemic lupus erythematosus	0.000158	0.00259	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000158	0.00259	CcSEcCtD
Ruxolitinib—Pruritus—Leflunomide—systemic lupus erythematosus	0.000157	0.00257	CcSEcCtD
Ruxolitinib—Neutropenia—Methotrexate—systemic lupus erythematosus	0.000156	0.00255	CcSEcCtD
Ruxolitinib—Dizziness—Azathioprine—systemic lupus erythematosus	0.000155	0.00255	CcSEcCtD
Ruxolitinib—Infection—Hydrocortisone—systemic lupus erythematosus	0.000151	0.00248	CcSEcCtD
Ruxolitinib—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000149	0.00245	CcSEcCtD
Ruxolitinib—Infestation—Methotrexate—systemic lupus erythematosus	0.000148	0.00243	CcSEcCtD
Ruxolitinib—Infestation NOS—Methotrexate—systemic lupus erythematosus	0.000148	0.00243	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000148	0.00243	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000148	0.00242	CcSEcCtD
Ruxolitinib—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000148	0.00242	CcSEcCtD
Ruxolitinib—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000148	0.00242	CcSEcCtD
Ruxolitinib—Headache—Azathioprine—systemic lupus erythematosus	0.000147	0.00241	CcSEcCtD
Ruxolitinib—Dizziness—Leflunomide—systemic lupus erythematosus	0.000147	0.00241	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000144	0.00237	CcSEcCtD
Ruxolitinib—Infection—Triamcinolone—systemic lupus erythematosus	0.000142	0.00234	CcSEcCtD
Ruxolitinib—Infection—Methylprednisolone—systemic lupus erythematosus	0.000142	0.00233	CcSEcCtD
Ruxolitinib—Haematuria—Methotrexate—systemic lupus erythematosus	0.000141	0.00232	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.00014	0.0023	CcSEcCtD
Ruxolitinib—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.00014	0.0023	CcSEcCtD
Ruxolitinib—Epistaxis—Methotrexate—systemic lupus erythematosus	0.00014	0.0023	CcSEcCtD
Ruxolitinib—Headache—Leflunomide—systemic lupus erythematosus	0.000139	0.00228	CcSEcCtD
Ruxolitinib—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000139	0.00228	CcSEcCtD
Ruxolitinib—Malnutrition—Prednisone—systemic lupus erythematosus	0.000139	0.00228	CcSEcCtD
Ruxolitinib—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000135	0.00222	CcSEcCtD
Ruxolitinib—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000134	0.0022	CcSEcCtD
Ruxolitinib—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000133	0.00218	CcSEcCtD
Ruxolitinib—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000132	0.00217	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000131	0.00216	CcSEcCtD
Ruxolitinib—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000131	0.00215	CcSEcCtD
Ruxolitinib—Infection—Dexamethasone—systemic lupus erythematosus	0.000129	0.00212	CcSEcCtD
Ruxolitinib—Infection—Betamethasone—systemic lupus erythematosus	0.000129	0.00212	CcSEcCtD
Ruxolitinib—Anaemia—Prednisone—systemic lupus erythematosus	0.000128	0.0021	CcSEcCtD
Ruxolitinib—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000127	0.00209	CcSEcCtD
Ruxolitinib—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000127	0.00209	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000127	0.00209	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000127	0.00209	CcSEcCtD
Ruxolitinib—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000123	0.00203	CcSEcCtD
Ruxolitinib—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000123	0.00202	CcSEcCtD
Ruxolitinib—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000123	0.00202	CcSEcCtD
Ruxolitinib—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000121	0.00199	CcSEcCtD
Ruxolitinib—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.00012	0.00197	CcSEcCtD
Ruxolitinib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.00012	0.00197	CcSEcCtD
Ruxolitinib—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.00194	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000117	0.00192	CcSEcCtD
Ruxolitinib—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000116	0.0019	CcSEcCtD
Ruxolitinib—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000113	0.00186	CcSEcCtD
Ruxolitinib—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000113	0.00186	CcSEcCtD
Ruxolitinib—Infection—Prednisone—systemic lupus erythematosus	0.000112	0.00185	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000112	0.00184	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000112	0.00184	CcSEcCtD
Ruxolitinib—Fatigue—Betamethasone—systemic lupus erythematosus	0.000112	0.00184	CcSEcCtD
Ruxolitinib—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000112	0.00184	CcSEcCtD
Ruxolitinib—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000111	0.00182	CcSEcCtD
Ruxolitinib—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.00011	0.00181	CcSEcCtD
Ruxolitinib—Skin disorder—Prednisone—systemic lupus erythematosus	0.00011	0.0018	CcSEcCtD
Ruxolitinib—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000109	0.00179	CcSEcCtD
Ruxolitinib—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000108	0.00177	CcSEcCtD
Ruxolitinib—Headache—Cyclosporine—systemic lupus erythematosus	0.000107	0.00176	CcSEcCtD
Ruxolitinib—Anaemia—Methotrexate—systemic lupus erythematosus	0.000107	0.00176	CcSEcCtD
Ruxolitinib—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000105	0.00172	CcSEcCtD
Ruxolitinib—Dizziness—Prednisolone—systemic lupus erythematosus	0.000103	0.00169	CcSEcCtD
Ruxolitinib—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000103	0.00169	CcSEcCtD
Ruxolitinib—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000103	0.00169	CcSEcCtD
Ruxolitinib—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000103	0.00169	CcSEcCtD
Ruxolitinib—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000103	0.00168	CcSEcCtD
Ruxolitinib—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000101	0.00166	CcSEcCtD
Ruxolitinib—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000101	0.00166	CcSEcCtD
Ruxolitinib—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000101	0.00165	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	9.8e-05	0.00161	CcSEcCtD
Ruxolitinib—Fatigue—Prednisone—systemic lupus erythematosus	9.76e-05	0.0016	CcSEcCtD
Ruxolitinib—Headache—Prednisolone—systemic lupus erythematosus	9.76e-05	0.0016	CcSEcCtD
Ruxolitinib—Headache—Hydrocortisone—systemic lupus erythematosus	9.53e-05	0.00156	CcSEcCtD
Ruxolitinib—Dizziness—Triamcinolone—systemic lupus erythematosus	9.47e-05	0.00155	CcSEcCtD
Ruxolitinib—Dizziness—Methylprednisolone—systemic lupus erythematosus	9.45e-05	0.00155	CcSEcCtD
Ruxolitinib—Infection—Methotrexate—systemic lupus erythematosus	9.4e-05	0.00154	CcSEcCtD
Ruxolitinib—Asthenia—Dexamethasone—systemic lupus erythematosus	9.33e-05	0.00153	CcSEcCtD
Ruxolitinib—Asthenia—Betamethasone—systemic lupus erythematosus	9.33e-05	0.00153	CcSEcCtD
Ruxolitinib—Nervous system disorder—Methotrexate—systemic lupus erythematosus	9.28e-05	0.00152	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	9.26e-05	0.00152	CcSEcCtD
Ruxolitinib—Pruritus—Betamethasone—systemic lupus erythematosus	9.2e-05	0.00151	CcSEcCtD
Ruxolitinib—Pruritus—Dexamethasone—systemic lupus erythematosus	9.2e-05	0.00151	CcSEcCtD
Ruxolitinib—Skin disorder—Methotrexate—systemic lupus erythematosus	9.19e-05	0.00151	CcSEcCtD
Ruxolitinib—Headache—Triamcinolone—systemic lupus erythematosus	8.97e-05	0.00147	CcSEcCtD
Ruxolitinib—Headache—Methylprednisolone—systemic lupus erythematosus	8.95e-05	0.00147	CcSEcCtD
Ruxolitinib—Body temperature increased—Prednisone—systemic lupus erythematosus	8.95e-05	0.00147	CcSEcCtD
Ruxolitinib—CYP3A4—kidney—systemic lupus erythematosus	8.91e-05	0.000911	CbGeAlD
Ruxolitinib—Dizziness—Dexamethasone—systemic lupus erythematosus	8.59e-05	0.00141	CcSEcCtD
Ruxolitinib—Dizziness—Betamethasone—systemic lupus erythematosus	8.59e-05	0.00141	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	8.17e-05	0.00134	CcSEcCtD
Ruxolitinib—Fatigue—Methotrexate—systemic lupus erythematosus	8.16e-05	0.00134	CcSEcCtD
Ruxolitinib—Headache—Dexamethasone—systemic lupus erythematosus	8.14e-05	0.00134	CcSEcCtD
Ruxolitinib—Headache—Betamethasone—systemic lupus erythematosus	8.14e-05	0.00134	CcSEcCtD
Ruxolitinib—Asthenia—Prednisone—systemic lupus erythematosus	8.12e-05	0.00133	CcSEcCtD
Ruxolitinib—Pruritus—Prednisone—systemic lupus erythematosus	8.01e-05	0.00131	CcSEcCtD
Ruxolitinib—Dizziness—Prednisone—systemic lupus erythematosus	7.48e-05	0.00123	CcSEcCtD
Ruxolitinib—Body temperature increased—Methotrexate—systemic lupus erythematosus	7.48e-05	0.00123	CcSEcCtD
Ruxolitinib—Headache—Prednisone—systemic lupus erythematosus	7.09e-05	0.00116	CcSEcCtD
Ruxolitinib—Asthenia—Methotrexate—systemic lupus erythematosus	6.79e-05	0.00111	CcSEcCtD
Ruxolitinib—Pruritus—Methotrexate—systemic lupus erythematosus	6.69e-05	0.0011	CcSEcCtD
Ruxolitinib—Dizziness—Methotrexate—systemic lupus erythematosus	6.26e-05	0.00103	CcSEcCtD
Ruxolitinib—Headache—Methotrexate—systemic lupus erythematosus	5.93e-05	0.000972	CcSEcCtD
Ruxolitinib—CYP3A4—nervous system—systemic lupus erythematosus	5.85e-05	0.000598	CbGeAlD
Ruxolitinib—CYP3A4—central nervous system—systemic lupus erythematosus	5.63e-05	0.000576	CbGeAlD
Ruxolitinib—TYK2—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.63e-06	2.38e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—IL2—systemic lupus erythematosus	3.63e-06	2.38e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CCR5—systemic lupus erythematosus	3.6e-06	2.36e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD8A—systemic lupus erythematosus	3.6e-06	2.36e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PRL—systemic lupus erythematosus	3.59e-06	2.36e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD80—systemic lupus erythematosus	3.57e-06	2.34e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NOS3—systemic lupus erythematosus	3.57e-06	2.34e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—TNF—systemic lupus erythematosus	3.55e-06	2.33e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	3.55e-06	2.33e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CD4—systemic lupus erythematosus	3.55e-06	2.33e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—EP300—systemic lupus erythematosus	3.54e-06	2.33e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—C3—systemic lupus erythematosus	3.52e-06	2.31e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—MMP9—systemic lupus erythematosus	3.5e-06	2.29e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—JAK1—systemic lupus erythematosus	3.47e-06	2.28e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CDKN1B—systemic lupus erythematosus	3.47e-06	2.28e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD80—systemic lupus erythematosus	3.46e-06	2.27e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—IL6—systemic lupus erythematosus	3.43e-06	2.25e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—IL6—systemic lupus erythematosus	3.42e-06	2.24e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CD4—systemic lupus erythematosus	3.41e-06	2.24e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—F2—systemic lupus erythematosus	3.4e-06	2.23e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL2—systemic lupus erythematosus	3.4e-06	2.23e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—PTGS2—systemic lupus erythematosus	3.38e-06	2.22e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CCL2—systemic lupus erythematosus	3.38e-06	2.22e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—TGFB1—systemic lupus erythematosus	3.37e-06	2.21e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—IL6—systemic lupus erythematosus	3.36e-06	2.21e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CDKN1B—systemic lupus erythematosus	3.34e-06	2.19e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—EP300—systemic lupus erythematosus	3.32e-06	2.18e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CD80—systemic lupus erythematosus	3.3e-06	2.16e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—F2—systemic lupus erythematosus	3.26e-06	2.14e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—EP300—systemic lupus erythematosus	3.25e-06	2.13e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL2RA—systemic lupus erythematosus	3.24e-06	2.13e-05	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—IL6—systemic lupus erythematosus	3.22e-06	2.11e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—C3—systemic lupus erythematosus	3.22e-06	2.11e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—F2—systemic lupus erythematosus	3.21e-06	2.11e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CDKN1B—systemic lupus erythematosus	3.21e-06	2.1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—JAK1—systemic lupus erythematosus	3.21e-06	2.1e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CDKN1A—systemic lupus erythematosus	3.2e-06	2.1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—VEGFA—systemic lupus erythematosus	3.14e-06	2.06e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CD80—systemic lupus erythematosus	3.13e-06	2.05e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—TYK2—systemic lupus erythematosus	3.11e-06	2.04e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.1e-06	2.04e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.09e-06	2.03e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—F2—systemic lupus erythematosus	3.09e-06	2.03e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—VEGFA—systemic lupus erythematosus	3.08e-06	2.02e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CDKN1A—systemic lupus erythematosus	3.08e-06	2.02e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CD80—systemic lupus erythematosus	3.08e-06	2.02e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TYK2—systemic lupus erythematosus	3.07e-06	2.01e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CRP—systemic lupus erythematosus	3.06e-06	2.01e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—JAK1—systemic lupus erythematosus	3.05e-06	2e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—EP300—systemic lupus erythematosus	3.05e-06	2e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—JUNB—systemic lupus erythematosus	3.05e-06	2e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—IL6—systemic lupus erythematosus	3.04e-06	2e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CCR5—systemic lupus erythematosus	3.04e-06	1.99e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—IL6—systemic lupus erythematosus	3.03e-06	1.99e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL2—systemic lupus erythematosus	3.03e-06	1.99e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NOS3—systemic lupus erythematosus	3.01e-06	1.98e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—IL6—systemic lupus erythematosus	3.01e-06	1.98e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—JAK1—systemic lupus erythematosus	2.96e-06	1.94e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CDKN1A—systemic lupus erythematosus	2.96e-06	1.94e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—TLR4—systemic lupus erythematosus	2.93e-06	1.92e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HLA-DRB1—systemic lupus erythematosus	2.93e-06	1.92e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—EP300—systemic lupus erythematosus	2.93e-06	1.92e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—TYK2—systemic lupus erythematosus	2.92e-06	1.92e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IFNG—systemic lupus erythematosus	2.91e-06	1.91e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CCL2—systemic lupus erythematosus	2.91e-06	1.91e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.89e-06	1.9e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CCR5—systemic lupus erythematosus	2.89e-06	1.9e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TGFB1—systemic lupus erythematosus	2.88e-06	1.89e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—JAK1—systemic lupus erythematosus	2.87e-06	1.88e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—IL6—systemic lupus erythematosus	2.87e-06	1.88e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MMP9—systemic lupus erythematosus	2.86e-06	1.88e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CCL2—systemic lupus erythematosus	2.86e-06	1.88e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.85e-06	1.87e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.85e-06	1.87e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—TGFB1—systemic lupus erythematosus	2.83e-06	1.86e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—C3—systemic lupus erythematosus	2.83e-06	1.85e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IFNG—systemic lupus erythematosus	2.82e-06	1.85e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—EP300—systemic lupus erythematosus	2.81e-06	1.85e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD4—systemic lupus erythematosus	2.81e-06	1.84e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PRL—systemic lupus erythematosus	2.81e-06	1.84e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCR5—systemic lupus erythematosus	2.81e-06	1.84e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.77e-06	1.81e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.75e-06	1.81e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL6—systemic lupus erythematosus	2.75e-06	1.8e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL2—systemic lupus erythematosus	2.75e-06	1.8e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—C3—systemic lupus erythematosus	2.74e-06	1.8e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IL6—systemic lupus erythematosus	2.74e-06	1.8e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IFNG—systemic lupus erythematosus	2.74e-06	1.8e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NOS3—systemic lupus erythematosus	2.73e-06	1.79e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD4—systemic lupus erythematosus	2.73e-06	1.79e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCR5—systemic lupus erythematosus	2.72e-06	1.79e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—EP300—systemic lupus erythematosus	2.72e-06	1.78e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD80—systemic lupus erythematosus	2.71e-06	1.78e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TNF—systemic lupus erythematosus	2.69e-06	1.77e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.68e-06	1.76e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—C3—systemic lupus erythematosus	2.66e-06	1.75e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD4—systemic lupus erythematosus	2.64e-06	1.73e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CDKN1B—systemic lupus erythematosus	2.64e-06	1.73e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TYK2—systemic lupus erythematosus	2.64e-06	1.73e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.61e-06	1.71e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—IL6—systemic lupus erythematosus	2.61e-06	1.71e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TYK2—systemic lupus erythematosus	2.6e-06	1.7e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NOS3—systemic lupus erythematosus	2.59e-06	1.7e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL2—systemic lupus erythematosus	2.58e-06	1.7e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.57e-06	1.69e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CDKN1B—systemic lupus erythematosus	2.56e-06	1.68e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL2—systemic lupus erythematosus	2.55e-06	1.68e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NOS3—systemic lupus erythematosus	2.55e-06	1.67e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—IL6—systemic lupus erythematosus	2.54e-06	1.67e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—IL6—systemic lupus erythematosus	2.54e-06	1.67e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—IL6—systemic lupus erythematosus	2.53e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL6—systemic lupus erythematosus	2.52e-06	1.65e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CD4—systemic lupus erythematosus	2.52e-06	1.65e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL2—systemic lupus erythematosus	2.51e-06	1.65e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.5e-06	1.64e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CD80—systemic lupus erythematosus	2.5e-06	1.64e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PTGS2—systemic lupus erythematosus	2.5e-06	1.64e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CDKN1B—systemic lupus erythematosus	2.49e-06	1.63e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—F2—systemic lupus erythematosus	2.48e-06	1.63e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL6—systemic lupus erythematosus	2.46e-06	1.61e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—IL6—systemic lupus erythematosus	2.46e-06	1.61e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—TGFB1—systemic lupus erythematosus	2.45e-06	1.61e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CDKN1A—systemic lupus erythematosus	2.44e-06	1.6e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL2—systemic lupus erythematosus	2.43e-06	1.6e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MMP9—systemic lupus erythematosus	2.42e-06	1.59e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—F2—systemic lupus erythematosus	2.41e-06	1.58e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.41e-06	1.58e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CD80—systemic lupus erythematosus	2.38e-06	1.56e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CDKN1B—systemic lupus erythematosus	2.37e-06	1.55e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CDKN1A—systemic lupus erythematosus	2.37e-06	1.55e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.36e-06	1.55e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—F2—systemic lupus erythematosus	2.34e-06	1.53e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL6—systemic lupus erythematosus	2.32e-06	1.52e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—EP300—systemic lupus erythematosus	2.32e-06	1.52e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CD80—systemic lupus erythematosus	2.31e-06	1.51e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CDKN1A—systemic lupus erythematosus	2.29e-06	1.51e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—EP300—systemic lupus erythematosus	2.29e-06	1.5e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.29e-06	1.5e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—TYK2—systemic lupus erythematosus	2.28e-06	1.5e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—EP300—systemic lupus erythematosus	2.25e-06	1.48e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—JAK1—systemic lupus erythematosus	2.24e-06	1.47e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.24e-06	1.47e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CD80—systemic lupus erythematosus	2.24e-06	1.47e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CCL2—systemic lupus erythematosus	2.21e-06	1.45e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.21e-06	1.45e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL2—systemic lupus erythematosus	2.2e-06	1.44e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—IL6—systemic lupus erythematosus	2.19e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CDKN1A—systemic lupus erythematosus	2.18e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—EP300—systemic lupus erythematosus	2.18e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—IL6—systemic lupus erythematosus	2.17e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.17e-06	1.42e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL2—systemic lupus erythematosus	2.16e-06	1.42e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—IL6—systemic lupus erythematosus	2.15e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCL2—systemic lupus erythematosus	2.15e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IFNG—systemic lupus erythematosus	2.14e-06	1.4e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCR5—systemic lupus erythematosus	2.13e-06	1.4e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TYK2—systemic lupus erythematosus	2.11e-06	1.38e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.1e-06	1.38e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCL2—systemic lupus erythematosus	2.08e-06	1.37e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL2—systemic lupus erythematosus	2.08e-06	1.37e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MMP9—systemic lupus erythematosus	2.08e-06	1.36e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—C3—systemic lupus erythematosus	2.08e-06	1.36e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—EP300—systemic lupus erythematosus	2.08e-06	1.36e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.07e-06	1.36e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS3—systemic lupus erythematosus	2.07e-06	1.36e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD4—systemic lupus erythematosus	2.07e-06	1.36e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MMP9—systemic lupus erythematosus	2.04e-06	1.34e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.04e-06	1.34e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TYK2—systemic lupus erythematosus	2.01e-06	1.32e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL6—systemic lupus erythematosus	2e-06	1.31e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.99e-06	1.31e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—EP300—systemic lupus erythematosus	1.97e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.97e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CDKN1B—systemic lupus erythematosus	1.94e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—EP300—systemic lupus erythematosus	1.94e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—IL6—systemic lupus erythematosus	1.92e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NOS3—systemic lupus erythematosus	1.91e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CD4—systemic lupus erythematosus	1.91e-06	1.25e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL2—systemic lupus erythematosus	1.9e-06	1.25e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PTGS2—systemic lupus erythematosus	1.89e-06	1.24e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TYK2—systemic lupus erythematosus	1.89e-06	1.24e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.87e-06	1.22e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NOS3—systemic lupus erythematosus	1.86e-06	1.22e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—IL6—systemic lupus erythematosus	1.84e-06	1.21e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.84e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—F2—systemic lupus erythematosus	1.83e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—TGFB1—systemic lupus erythematosus	1.81e-06	1.19e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CDKN1B—systemic lupus erythematosus	1.79e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CDKN1A—systemic lupus erythematosus	1.79e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL6—systemic lupus erythematosus	1.78e-06	1.17e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CD80—systemic lupus erythematosus	1.75e-06	1.15e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.71e-06	1.12e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.71e-06	1.12e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—EP300—systemic lupus erythematosus	1.71e-06	1.12e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.69e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL2—systemic lupus erythematosus	1.67e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.66e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CDKN1A—systemic lupus erythematosus	1.66e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCL2—systemic lupus erythematosus	1.63e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL2—systemic lupus erythematosus	1.62e-06	1.06e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL6—systemic lupus erythematosus	1.61e-06	1.06e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.61e-06	1.06e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.61e-06	1.05e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.58e-06	1.04e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.58e-06	1.03e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—EP300—systemic lupus erythematosus	1.57e-06	1.03e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL2—systemic lupus erythematosus	1.57e-06	1.03e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MMP9—systemic lupus erythematosus	1.53e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.53e-06	1e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL6—systemic lupus erythematosus	1.52e-06	9.96e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL6—systemic lupus erythematosus	1.5e-06	9.85e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—EP300—systemic lupus erythematosus	1.5e-06	9.84e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MMP9—systemic lupus erythematosus	1.49e-06	9.77e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.48e-06	9.73e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TYK2—systemic lupus erythematosus	1.48e-06	9.69e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL6—systemic lupus erythematosus	1.47e-06	9.67e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—EP300—systemic lupus erythematosus	1.46e-06	9.55e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NOS3—systemic lupus erythematosus	1.45e-06	9.51e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL6—systemic lupus erythematosus	1.43e-06	9.38e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.42e-06	9.31e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—EP300—systemic lupus erythematosus	1.41e-06	9.26e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.38e-06	9.04e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TGFB1—systemic lupus erythematosus	1.37e-06	8.98e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—IL6—systemic lupus erythematosus	1.36e-06	8.93e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.34e-06	8.77e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.3e-06	8.55e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL6—systemic lupus erythematosus	1.29e-06	8.47e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL6—systemic lupus erythematosus	1.27e-06	8.33e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.26e-06	8.3e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.26e-06	8.24e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL2—systemic lupus erythematosus	1.23e-06	8.06e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.23e-06	8.05e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL6—systemic lupus erythematosus	1.22e-06	8.02e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MMP9—systemic lupus erythematosus	1.16e-06	7.63e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.16e-06	7.6e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL6—systemic lupus erythematosus	1.12e-06	7.33e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—EP300—systemic lupus erythematosus	1.1e-06	7.24e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.04e-06	6.85e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—IL6—systemic lupus erythematosus	1.03e-06	6.77e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL6—systemic lupus erythematosus	9.82e-07	6.44e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.59e-07	6.29e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL6—systemic lupus erythematosus	9.53e-07	6.25e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL6—systemic lupus erythematosus	9.25e-07	6.07e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	9.02e-07	5.92e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL6—systemic lupus erythematosus	7.22e-07	4.74e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	5.7e-07	3.74e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	5.12e-07	3.36e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	4.9e-07	3.22e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	4.48e-07	2.94e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	3.73e-07	2.45e-06	CbGpPWpGaD
